Fenwick & West represented Science Exchange, Inc., a leading marketplace for scientific research, in its $25 million Series B financing. Maverick Capital Ventures led the latest round with participation from Union Square Ventures, Index Ventures, YC Continuity Fund, Sam Altman, and others. As part of the funding, Maverick Capital Ventures Managing Partner David Singer will join the company’s board.
Science Exchange will use the funds to grow its team in all areas including product, engineering, sales, marketing and customer success. More information about Science Exchange’s $25 million Series B financing can be obtained from the company press release.